The University of Chicago Header Logo

Connection

Jon E. Grant to Drug Resistance

This is a "connection" page, showing publications Jon E. Grant has written about Drug Resistance.
Connection Strength

0.937
  1. Double-blind switch study of vilazodone in the treatment of major depressive disorder. Int Clin Psychopharmacol. 2017 05; 32(3):121-126.
    View in: PubMed
    Score: 0.547
  2. Time to Reconsider Monoamine Oxidase Inhibitors for Obsessive Compulsive Disorder?: A Case Series Using Phenelzine. J Clin Psychopharmacol. 2021 Jul-Aug 01; 41(4):461-464.
    View in: PubMed
    Score: 0.183
  3. Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2013 Jun; 74(6):e527-32.
    View in: PubMed
    Score: 0.104
  4. Memantine reduces stealing behavior and impulsivity in kleptomania: a pilot study. Int Clin Psychopharmacol. 2013 Mar; 28(2):106-11.
    View in: PubMed
    Score: 0.102
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.